Latest Contracts News

Meridian Energy posted a significant net loss for FY25 due to severe droughts and gas shortages but pushed ahead with renewable investments and maintained shareholder dividends.

EBOS Group Limited reported a 7% drop in revenue and a 21% fall in net profit for FY2025, reflecting ongoing cost pressures and restructuring impacts. The company declared a final dividend, signaling cautious optimism despite the earnings setback.

EBOS Group Limited reported solid FY25 results with 12% revenue growth and strategic acquisitions, setting sights on continued expansion and operational efficiency in FY26.

EBOS Group Limited reported a steady FY25 with 12% revenue growth and EBITDA in line with guidance, driven by strong healthcare and animal care segments. The company signals confidence with maintained dividends and a positive FY26 outlook.

EBOS Group Limited has reported a 7% decline in revenue and a 21% drop in net profit for FY2025, yet it maintains its final dividend at 61.5 NZ cents per share. The results reflect ongoing cost pressures and restructuring expenses amid a challenging market environment.

RPMGlobal completes its transition to a pure-play software company, reporting robust FY25 results driven by subscription revenue growth and a $63.6 million Advisory divestment. The company projects significant margin expansion and revenue growth in FY26 backed by a $200 million contract backlog.

AUCyber Limited reported a 112% revenue increase to $23 million in FY25, driven by acquisitions and cybersecurity growth, despite a $37.6 million net loss largely due to impairment charges. The company’s strategic pivot under 5G Networks’ majority ownership signals a renewed focus on sovereign cloud and AI-enhanced security services.

Dubber Corporation Limited will record a significant non-cash impairment charge in FY25 following the loss of a major customer contract with Virgin Media O2, impacting its intangible assets from a prior acquisition.

DataDot Technology Limited reported a 13% revenue increase and a 56% rise in net profit after tax for FY25, driven by growth in its PropertyVAULT insurance services and new distributor partnerships.

Cleo Diagnostics reported a $4 million loss for FY2025 while making significant strides toward FDA approval of its novel ovarian cancer blood test. The company is progressing clinical trials and scaling manufacturing in preparation for market entry.

Wagners Holding Company Limited reported a robust FY25 with revenue growth led by construction materials and composite fibre technologies, alongside strategic expansion and debt reduction.

Wagners Holding Company Limited reported a 120% increase in net profit after tax for FY25 despite a 10.4% revenue decline, driven by strong segment performance and cost management. The company also declared a higher fully franked final dividend of 3.2 cents per share.